Yeleswaram Krishnaswamy

Rapport Therapeutics, Inc. Common Stock · Chief Development Officer

Yeleswaram Krishnaswamy is listed in public filings as officer: Chief Development Officer. This Yeleswaram Krishnaswamy insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Rapport Therapeutics, Inc. Common Stock (RAPP). Investors use Yeleswaram Krishnaswamy's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Rapport Therapeutics, Inc. Common StockRAPP$9.9M246.4k sharesSellApr 17, 2026$808.8K20.2k shares$39.99--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Rapport Therapeutics, Inc. Common StockRAPP$9.4M266.7k sharesSellApr 14, 2026$357.8K10.2k shares$35.08--
Rapport Therapeutics, Inc. Common StockRAPP$9.7M276.9k sharesSellApr 13, 2026$320.5K9.2k shares$34.97--
Rapport Therapeutics, Inc. Common StockRAPP$10M286k sharesSellApr 10, 2026$17.5K500 shares$34.98--
Rapport Therapeutics, Inc. Common StockRAPP$10.0M286.5k sharesSellApr 8, 2026$12.6K360 shares$34.90--
Rapport Therapeutics, Inc. Common StockRAPP$8.6M286.9k sharesSellMar 25, 2026$303.4K10.1k shares$29.99--
Rapport Therapeutics, Inc. Common StockRAPP$3.3M120k sharesGrant / ExerciseFeb 2, 2026$3.3M120k shares$27.75--
Rapport Therapeutics, Inc. Common StockRAPP--299.8k sharesGrant / ExerciseDec 31, 2025Disclosure amount unavailable9k shares----
Rapport Therapeutics, Inc. Common StockRAPP$8.9M297k sharesSellDec 31, 2025$85.3K2.8k shares$30.05--
Rapport Therapeutics, Inc. Common StockRAPP$1.8M110k sharesGrant / ExerciseFeb 3, 2025$1.8M110k shares$16.60--